PPD

PPD

Contract Research Organization (CRO) Clinical Trial Solutions with PPD. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD23.7b (Public information from Apr 2021)
Wilmington North Carolina (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Growth Equity VC
N/A

N/A

IPO

$17.4b

Valuation: $17.4b

Acquisition

$3.5b

Post IPO Debt
Total Funding-

Recent News about PPD

Edit
More about PPDinfo icon
Edit

PPD is a global contract research organization (CRO) that specializes in providing clinical research services to small to mid-sized biotech and pharmaceutical companies. The company operates in the healthcare and life sciences market, focusing on accelerating drug development through the integration of real-world data (RWD), predictive analytics, and AI-powered algorithms. PPD's business model revolves around offering comprehensive clinical research solutions, including study planning, data management, and regulatory compliance. The company generates revenue by partnering with clients to conduct clinical trials and providing actionable insights that enhance the efficiency and success rate of drug development programs. PPD leverages advanced technology and the services of Thermo Fisher Scientific to deliver high-quality, ethical, and compliant research outcomes.

Keywords: clinical research, drug development, biotech, pharma, real-world data, predictive analytics, AI algorithms, regulatory compliance, study planning, Thermo Fisher Scientific.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
  • Edit
Magen BioSciences
ACQUISITION by PPD Apr 2009
AbCRO
ACQUISITION by PPD Apr 2009
Evidera
ACQUISITION by PPD Aug 2016
Excel PharmaStudies
ACQUISITION by PPD Oct 2009
RCT Logic
ACQUISITION by PPD Sep 2014
BioDuro
ACQUISITION by Advent International Feb 2019
Science 37
ACQUISITION by EMed Technologies Jan 2024
X-Chem
ACQUISITION by PPD Sep 2014